Annual report
6856.TEDINET S100T3YZ
Period2023-01-01 → 2023-12-31
Filed2024-03-25
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 158
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥290.6bn | 2023-01-01 → 2023-12-31 | Cons. | Net sales |
| Revenue | ¥270.1bn | 2022-01-01 → 2022-12-31 | Cons. | Net sales |
| Revenue | ¥224.3bn | 2021-01-01 → 2021-12-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥187.1bn | 2020-01-01 → 2020-12-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥200.2bn | 2019-01-01 → 2019-12-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥47.3bn | 2023-01-01 → 2023-12-31 | Cons. | Operating income |
| Operating income | ¥45.8bn | 2022-01-01 → 2022-12-31 | Cons. | Operating income |
| Ordinary income | ¥48.3bn | 2023-01-01 → 2023-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥46.9bn | 2022-01-01 → 2022-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥32.0bn | 2021-01-01 → 2021-12-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥19.4bn | 2020-01-01 → 2020-12-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥20.5bn | 2019-01-01 → 2019-12-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥53.7bn | 2023-01-01 → 2023-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥47.3bn | 2022-01-01 → 2022-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥40.3bn | 2023-01-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥34.1bn | 2022-01-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥21.3bn | 2021-01-01 → 2021-12-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥13.2bn | 2020-01-01 → 2020-12-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥15.5bn | 2019-01-01 → 2019-12-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥40.3bn | 2023-01-01 → 2023-12-31 | Cons. | Profit loss |
| Net income | ¥34.1bn | 2022-01-01 → 2022-12-31 | Cons. | Profit loss |
| Total assets | ¥449.0bn | at 2023-12-31 | Cons. | Assets |
| Total assets | ¥416.7bn | at 2022-12-31 | Cons. | Assets |
| Total assets | ¥371.6bn | at 2021-12-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥328.1bn | at 2020-12-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥315.1bn | at 2019-12-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥165.3bn | at 2023-12-31 | Cons. | Liabilities |
| Total liabilities | ¥175.9bn | at 2022-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥283.7bn | at 2023-12-31 | Cons. | Net assets |
| Net assets / equity | ¥240.8bn | at 2022-12-31 | Cons. | Net assets |
| Net assets / equity | ¥204.5bn | at 2021-12-31d | Cons. | Net assets |
| Net assets / equity | ¥178.7bn | at 2020-12-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥171.6bn | at 2019-12-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥132.8bn | at 2023-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥139.9bn | at 2022-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥130.6bn | at 2023-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥138.8bn | at 2022-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥133.9bn | at 2021-12-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥114.2bn | at 2020-12-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥96.1bn | at 2019-12-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥16.7bn | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥34.0bn | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥35.3bn | 2021-01-01 → 2021-12-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥32.3bn | 2020-01-01 → 2020-12-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥26.6bn | 2019-01-01 → 2019-12-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥7.3bn | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥10.7bn | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥14.7bn | 2021-01-01 → 2021-12-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥14.0bn | 2020-01-01 → 2020-12-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥12.4bn | 2019-01-01 → 2019-12-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥21.0bn | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥22.4bn | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥4.0bn | 2021-01-01 → 2021-12-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥843m | 2020-01-01 → 2020-12-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥19.2bn | 2019-01-01 → 2019-12-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥953.71 | 2023-01-01 → 2023-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥807.06 | 2022-01-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥505.05 | 2021-01-01 → 2021-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥312.58 | 2020-01-01 → 2020-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥367.09 | 2019-01-01 → 2019-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥948.83 | 2023-01-01 → 2023-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥802.89 | 2022-01-01 → 2022-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥502.46 | 2021-01-01 → 2021-12-31d | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥311.09 | 2020-01-01 → 2020-12-31d | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥365.44 | 2019-01-01 → 2019-12-31d | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥6,695.3 | at 2023-12-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥5,684.68 | at 2022-12-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥4,827.06 | at 2021-12-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥4,217.45 | at 2020-12-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥4,053.3 | at 2019-12-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 63.0% | at 2023-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 57.6% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 54.8% | at 2021-12-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 54.3% | at 2020-12-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 54.3% | at 2019-12-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 15.4% | 2023-01-01 → 2023-12-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 15.4% | 2022-01-01 → 2022-12-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 11.2% | 2021-01-01 → 2021-12-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 7.6% | 2020-01-01 → 2020-12-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 9.3% | 2019-01-01 → 2019-12-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 8,665 | at 2023-12-31 | Cons. | Number of employees |
| Employees | 8,432 | at 2022-12-31 | Cons. | Number of employees |
| Employees | 8,205 | at 2021-12-31d | Cons. | Number of employees |
| Employees | 8,269 | at 2020-12-31d | Cons. | Number of employees |
| Employees | 8,288 | at 2019-12-31d | Cons. | Number of employees |
| Revenue | ¥54.6bn | 2023-01-01 → 2023-12-31 | Standalone | Net sales |
| Revenue | ¥51.9bn | 2022-01-01 → 2022-12-31 | Standalone | Net sales |
| Revenue | ¥50.0bn | 2021-01-01 → 2021-12-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥50.1bn | 2020-01-01 → 2020-12-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥64.0bn | 2019-01-01 → 2019-12-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥5.2bn | 2023-01-01 → 2023-12-31 | Standalone | Operating income |
| Operating income | ¥3.8bn | 2022-01-01 → 2022-12-31 | Standalone | Operating income |
| Ordinary income | ¥24.0bn | 2023-01-01 → 2023-12-31 | Standalone | Ordinary income |
| Ordinary income | ¥16.0bn | 2022-01-01 → 2022-12-31 | Standalone | Ordinary income |
| Ordinary income | ¥9.7bn | 2021-01-01 → 2021-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥8.2bn | 2020-01-01 → 2020-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥13.7bn | 2019-01-01 → 2019-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥23.9bn | 2023-01-01 → 2023-12-31 | Standalone | Income before income taxes |
| Profit before tax | ¥15.8bn | 2022-01-01 → 2022-12-31 | Standalone | Income before income taxes |
| Net income | ¥22.7bn | 2023-01-01 → 2023-12-31 | Standalone | Profit loss |
| Net income | ¥14.6bn | 2022-01-01 → 2022-12-31 | Standalone | Profit loss |
| Net income | ¥1.9bn | 2021-01-01 → 2021-12-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥7.3bn | 2020-01-01 → 2020-12-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥11.8bn | 2019-01-01 → 2019-12-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥224.6bn | at 2023-12-31 | Standalone | Assets |
| Total assets | ¥223.0bn | at 2022-12-31 | Standalone | Assets |
| Total assets | ¥221.8bn | at 2021-12-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥214.2bn | at 2020-12-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥207.5bn | at 2019-12-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥90.5bn | at 2023-12-31 | Standalone | Liabilities |
| Total liabilities | ¥103.4bn | at 2022-12-31 | Standalone | Liabilities |
| Net assets / equity | ¥134.1bn | at 2023-12-31 | Standalone | Net assets |
| Net assets / equity | ¥119.7bn | at 2022-12-31 | Standalone | Net assets |
| Net assets / equity | ¥113.2bn | at 2021-12-31d | Standalone | Net assets |
| Net assets / equity | ¥114.7bn | at 2020-12-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥111.9bn | at 2019-12-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥37.8bn | at 2023-12-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥52.9bn | at 2022-12-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥537.92 | 2023-01-01 → 2023-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥344.94 | 2022-01-01 → 2022-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥45.03 | 2021-01-01 → 2021-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥172.02 | 2020-01-01 → 2020-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥280.18 | 2019-01-01 → 2019-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥535.17 | 2023-01-01 → 2023-12-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥343.16 | 2022-01-01 → 2022-12-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥44.8 | 2021-01-01 → 2021-12-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥171.2 | 2020-01-01 → 2020-12-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥278.92 | 2019-01-01 → 2019-12-31d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥290 | 2023-01-01 → 2023-12-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥245 | 2022-01-01 → 2022-12-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥150 | 2021-01-01 → 2021-12-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥90 | 2020-01-01 → 2020-12-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥130 | 2019-01-01 → 2019-12-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥3,156.37 | at 2023-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,815.8 | at 2022-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,664.43 | at 2021-12-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,700.73 | at 2020-12-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,638.66 | at 2019-12-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 59.4% | at 2023-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 53.3% | at 2022-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 50.7% | at 2021-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 53.2% | at 2020-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 53.6% | at 2019-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 18.0% | 2023-01-01 → 2023-12-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 12.6% | 2022-01-01 → 2022-12-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 1.7% | 2021-01-01 → 2021-12-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 6.4% | 2020-01-01 → 2020-12-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 11.0% | 2019-01-01 → 2019-12-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 42,532,000 | at 2023-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 42,532,000 | at 2022-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 42,532,000 | at 2021-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 42,532,000 | at 2020-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 42,532,000 | at 2019-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 1,510 | at 2023-12-31 | Standalone | Number of employees |
| Employees | 1,484 | at 2022-12-31 | Standalone | Number of employees |
| Employees | 1,542 | at 2021-12-31d | Standalone | Number of employees |
| Employees | 1,623 | at 2020-12-31d | Standalone | Number of employees |
| Employees | 1,702 | at 2019-12-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 72
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment assets | at 2023-12-31 | ¥151.3bn |
| Automotivereportable segment | capex | 2023-01-01 → 2023-12-31 | ¥4.1bn |
| Automotivereportable segment | depreciation | 2023-01-01 → 2023-12-31 | ¥4.5bn |
| Automotivereportable segment | employees | at 2023-12-31 | 2611 pure |
| Automotivereportable segment | revenue | 2023-01-01 → 2023-12-31 | ¥80.4bn |
| Automotivereportable segment | revenue external | 2023-01-01 → 2023-12-31 | ¥80.4bn |
| Automotivereportable segment | segment assets | at 2023-12-31 | ¥103.8bn |
| Automotivereportable segment | segment profit | 2023-01-01 → 2023-12-31 | ¥1.2bn |
| Medical Diagnosticreportable segment | capex | 2023-01-01 → 2023-12-31 | ¥1.2bn |
| Medical Diagnosticreportable segment | depreciation | 2023-01-01 → 2023-12-31 | ¥2.1bn |
| Medical Diagnosticreportable segment | employees | at 2023-12-31 | 1197 pure |
| Medical Diagnosticreportable segment | revenue | 2023-01-01 → 2023-12-31 | ¥32.7bn |
| Medical Diagnosticreportable segment | revenue external | 2023-01-01 → 2023-12-31 | ¥32.7bn |
| Medical Diagnosticreportable segment | segment assets | at 2023-12-31 | ¥30.9bn |
| Medical Diagnosticreportable segment | segment profit | 2023-01-01 → 2023-12-31 | ¥638m |
| Process And Environmentalreportable segment | capex | 2023-01-01 → 2023-12-31 | ¥548m |
| Process And Environmentalreportable segment | depreciation | 2023-01-01 → 2023-12-31 | ¥819m |
| Process And Environmentalreportable segment | employees | at 2023-12-31 | 677 pure |
| Process And Environmentalreportable segment | revenue | 2023-01-01 → 2023-12-31 | ¥25.0bn |
| Process And Environmentalreportable segment | revenue external | 2023-01-01 → 2023-12-31 | ¥25.0bn |
| Process And Environmentalreportable segment | segment assets | at 2023-12-31 | ¥23.5bn |
| Process And Environmentalreportable segment | segment profit | 2023-01-01 → 2023-12-31 | ¥2.4bn |
| Scientificreportable segment | capex | 2023-01-01 → 2023-12-31 | ¥986m |
| Scientificreportable segment | depreciation | 2023-01-01 → 2023-12-31 | ¥1.5bn |
| Scientificreportable segment | employees | at 2023-12-31 | 1071 pure |
| Scientificreportable segment | revenue | 2023-01-01 → 2023-12-31 | ¥39.6bn |
| Scientificreportable segment | revenue external | 2023-01-01 → 2023-12-31 | ¥39.6bn |
| Scientificreportable segment | segment assets | at 2023-12-31 | ¥37.0bn |
| Scientificreportable segment | segment profit | 2023-01-01 → 2023-12-31 | ¥2.5bn |
| Semiconductorreportable segment | capex | 2023-01-01 → 2023-12-31 | ¥2.3bn |
| Semiconductorreportable segment | depreciation | 2023-01-01 → 2023-12-31 | ¥3.2bn |
| Semiconductorreportable segment | employees | at 2023-12-31 | 1326 pure |
| Semiconductorreportable segment | revenue | 2023-01-01 → 2023-12-31 | ¥112.9bn |
| Semiconductorreportable segment | revenue external | 2023-01-01 → 2023-12-31 | ¥112.9bn |
| Semiconductorreportable segment | segment assets | at 2023-12-31 | ¥102.5bn |
| Semiconductorreportable segment | segment profit | 2023-01-01 → 2023-12-31 | ¥40.6bn |
| Reconciling Itemsreconciling | segment assets | at 2022-12-31 | ¥155.6bn |
| Automotivereportable segment | capex | 2022-01-01 → 2022-12-31 | ¥5.5bn |
| Automotivereportable segment | depreciation | 2022-01-01 → 2022-12-31 | ¥3.9bn |
| Automotivereportable segment | revenue | 2022-01-01 → 2022-12-31 | ¥67.5bn |
| Automotivereportable segment | revenue external | 2022-01-01 → 2022-12-31 | ¥67.5bn |
| Automotivereportable segment | segment assets | at 2022-12-31 | ¥84.2bn |
| Automotivereportable segment | segment profit | 2022-01-01 → 2022-12-31 | −¥667m |
| Medical Diagnosticreportable segment | capex | 2022-01-01 → 2022-12-31 | ¥1.6bn |
| Medical Diagnosticreportable segment | depreciation | 2022-01-01 → 2022-12-31 | ¥2.0bn |
| Medical Diagnosticreportable segment | revenue | 2022-01-01 → 2022-12-31 | ¥29.8bn |
| Medical Diagnosticreportable segment | revenue external | 2022-01-01 → 2022-12-31 | ¥29.8bn |
| Medical Diagnosticreportable segment | segment assets | at 2022-12-31 | ¥28.5bn |
| Medical Diagnosticreportable segment | segment profit | 2022-01-01 → 2022-12-31 | −¥99m |
| Process And Environmentalreportable segment | capex | 2022-01-01 → 2022-12-31 | ¥829m |
| Process And Environmentalreportable segment | depreciation | 2022-01-01 → 2022-12-31 | ¥727m |
| Process And Environmentalreportable segment | revenue | 2022-01-01 → 2022-12-31 | ¥22.5bn |
| Process And Environmentalreportable segment | revenue external | 2022-01-01 → 2022-12-31 | ¥22.5bn |
| Process And Environmentalreportable segment | segment assets | at 2022-12-31 | ¥19.7bn |
| Process And Environmentalreportable segment | segment profit | 2022-01-01 → 2022-12-31 | ¥2.1bn |
| Scientificreportable segment | capex | 2022-01-01 → 2022-12-31 | ¥1.3bn |
| Scientificreportable segment | depreciation | 2022-01-01 → 2022-12-31 | ¥1.2bn |
| Scientificreportable segment | revenue | 2022-01-01 → 2022-12-31 | ¥36.2bn |
| Scientificreportable segment | revenue external | 2022-01-01 → 2022-12-31 | ¥36.2bn |
| Scientificreportable segment | segment assets | at 2022-12-31 | ¥31.2bn |
| Scientificreportable segment | segment profit | 2022-01-01 → 2022-12-31 | ¥2.5bn |
| Semiconductorreportable segment | capex | 2022-01-01 → 2022-12-31 | ¥3.3bn |
| Semiconductorreportable segment | depreciation | 2022-01-01 → 2022-12-31 | ¥3.0bn |
| Semiconductorreportable segment | revenue | 2022-01-01 → 2022-12-31 | ¥114.1bn |
| Semiconductorreportable segment | revenue external | 2022-01-01 → 2022-12-31 | ¥114.1bn |
| Semiconductorreportable segment | segment assets | at 2022-12-31 | ¥97.5bn |
| Semiconductorreportable segment | segment profit | 2022-01-01 → 2022-12-31 | ¥42.0bn |
| Automotivereportable segment | employees | at 2023-12-31 | 364 pure |
| Medical Diagnosticreportable segment | employees | at 2023-12-31 | 142 pure |
| Process And Environmentalreportable segment | employees | at 2023-12-31 | 150 pure |
| Scientificreportable segment | employees | at 2023-12-31 | 126 pure |
| Semiconductorreportable segment | employees | at 2023-12-31 | 31 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,775
| Item | Context | Value | Unit |
|---|---|---|---|
| Total return on share price index | Prior2YearInstant_NonConsolidatedMember | 1.334 | |
| Total return on share price index | Prior1YearInstant_NonConsolidatedMember | 1.266 | |
| Total return on share price index | CurrentYearInstant_NonConsolidatedMember | 1.584 | |
| Number of employees | CurrentYearInstant_jpcrp030000-asr_E01901-000AutomotiveReportableSegmentMember | 2611 | |
| Number of employees | CurrentYearInstant_jpcrp030000-asr_E01901-000ProcessAndEnvironmentalReportableSegmentMember | 677 | |
| Number of employees | CurrentYearInstant_jpcrp030000-asr_E01901-000MedicalDiagnosticReportableSegmentMember | 1197 | |
| Number of employees | CurrentYearInstant_jpcrp030000-asr_E01901-000SemiconductorReportableSegmentMember | 1326 | |
| Number of employees | CurrentYearInstant_jpcrp030000-asr_E01901-000ScientificReportableSegmentMember | 1071 | |
| Number of employees | CurrentYearInstant_CorporateSharedMember | 1783 | |
| Number of employees | CurrentYearInstant | 8665 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember | 1510 | |
| Average age years information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 42.4 | |
| Average length of service years information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 15.9 | |
| Average annual salary information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 6924127 | JPY |
| Number of employees | CurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E01901-000AutomotiveReportableSegmentMember | 364 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E01901-000ProcessAndEnvironmentalReportableSegmentMember | 150 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E01901-000MedicalDiagnosticReportableSegmentMember | 142 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E01901-000SemiconductorReportableSegmentMember | 31 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E01901-000ScientificReportableSegmentMember | 126 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember_CorporateSharedMember | 697 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember | 1510 | |
| Research and development expenses research and development activities | CurrentYearDuration | 20436000000 | JPY |
| Research and development expenses research and development activities | CurrentYearDuration_jpcrp030000-asr_E01901-000AutomotiveReportableSegmentMember | 5353000000 | JPY |
| Research and development expenses research and development activities | CurrentYearDuration_jpcrp030000-asr_E01901-000ProcessAndEnvironmentalReportableSegmentMember | 2021000000 | JPY |
| Research and development expenses research and development activities | CurrentYearDuration_jpcrp030000-asr_E01901-000MedicalDiagnosticReportableSegmentMember | 3111000000 | JPY |
| Research and development expenses research and development activities | CurrentYearDuration_jpcrp030000-asr_E01901-000SemiconductorReportableSegmentMember | 6049000000 | JPY |
| Research and development expenses research and development activities | CurrentYearDuration_jpcrp030000-asr_E01901-000ScientificReportableSegmentMember | 3899000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration | 9122000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E01901-000AutomotiveReportableSegmentMember | 4102000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E01901-000ProcessAndEnvironmentalReportableSegmentMember | 548000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E01901-000MedicalDiagnosticReportableSegmentMember | 1198000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E01901-000SemiconductorReportableSegmentMember | 2285000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E01901-000ScientificReportableSegmentMember | 986000000 | JPY |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 42532752 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 42532752 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 42532752 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 42532752 | |
| Number of shares constituting one unit | CurrentYearInstant_OrdinaryShareMember | 100 | |
| Number of shareholders national and local governments | CurrentYearInstant_OrdinaryShareMember | － | |
| Number of shareholders financial institutions | CurrentYearInstant_OrdinaryShareMember | 54 | |
| Number of shareholders financial service providers | CurrentYearInstant_OrdinaryShareMember | 31 | |
| Number of shareholders other corporations | CurrentYearInstant_OrdinaryShareMember | 171 | |
| Number of shareholders foreign investors other than individuals | CurrentYearInstant_OrdinaryShareMember | 387 | |
| Number of shareholders foreign individual investors | CurrentYearInstant_OrdinaryShareMember | 15 | |
| Number of shareholders individuals and others | CurrentYearInstant_OrdinaryShareMember | 5884 | |
| Number of shareholders total | CurrentYearInstant_OrdinaryShareMember | 6542 | |
| Number of shares held number of units national and local governments | CurrentYearInstant_OrdinaryShareMember | － | |
| Number of shares held number of units financial institutions | CurrentYearInstant_OrdinaryShareMember | 152225 | |
| Number of shares held number of units financial service providers | CurrentYearInstant_OrdinaryShareMember | 12407 | |
| Number of shares held number of units other corporations | CurrentYearInstant_OrdinaryShareMember | 27785 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |